ACF Investors — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Neurovalensneurovalens.comin𝕏Seed · Jul 2017 · $1M
Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders.
BiotechDeep TechHealthtechMedical DevicesMental HealthNorthern Ireland, GB
Dr. Jason McKeown(MD PhD, Founder)
Co-investorsClarendon Fund Managers Ltd.IQ CapitalBeltrae PartnersBritish Business BankInvest Northern IrelandTechstart Ventures
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.